Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 3
2019 3
2020 3
2021 6
2022 3
2023 1
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Identification of genetic subtypes in follicular lymphoma.
Shelton V, Detroja R, Liu T, Isaev K, Silva A, Passerini V, Bakhtiari M, Calvente L, Hong M, He MY, Modi S, Hershenfeld SA, Ludvigsen M, Madsen C, Hamilton-Dutoit S, d'Amore FA, Brodtkorb M, Johnson NA, Baetz T, LeBrun D, Tobin JWD, Gandhi MK, Mungall AJ, Xu W, Ben-Neriah S, Steidl C, Delabie J, Tremblay-LeMay R, Jegede O, Weigert O, Kahl B, Evens AM, Kridel R. Shelton V, et al. Blood Cancer J. 2024 Aug 7;14(1):128. doi: 10.1038/s41408-024-01111-w. Blood Cancer J. 2024. PMID: 39112453 Free PMC article.
Inherent genome instability underlies trisomy 21-associated myeloid malignancies.
Chen CC, Silberman RE, Ma D, Perry JA, Khalid D, Pikman Y, Amon A, Hemann MT, Rowe RG. Chen CC, et al. Leukemia. 2024 Mar;38(3):521-529. doi: 10.1038/s41375-024-02151-8. Epub 2024 Jan 20. Leukemia. 2024. PMID: 38245602
Constitutional trisomy 21 (T21) is a state of aneuploidy associated with high incidence of childhood acute myeloid leukemia (AML). T21-associated AML is preceded by transient abnormal myelopoiesis (TAM), which is triggered by truncating mutations in GATA1 generating a shor …
Constitutional trisomy 21 (T21) is a state of aneuploidy associated with high incidence of childhood acute myeloid leukemia (AML). T2 …
The Pleiotropy of PAX5 Gene Products and Function.
Nasri Nasrabadi P, Martin D, Gharib E, Robichaud GA. Nasri Nasrabadi P, et al. Int J Mol Sci. 2022 Sep 3;23(17):10095. doi: 10.3390/ijms231710095. Int J Mol Sci. 2022. PMID: 36077495 Free PMC article. Review.
Clinical Proteomics for Post-Hematopoeitic Stem Cell Transplantation Outcomes.
Paczesny S, Metzger J. Paczesny S, et al. Proteomics Clin Appl. 2019 Mar;13(2):e1800145. doi: 10.1002/prca.201800145. Epub 2018 Oct 17. Proteomics Clin Appl. 2019. PMID: 30307119 Free PMC article. Review.
However, while HSCT can induce beneficial graft-versus-leukemia (GVL) effect, the adverse effect of graft-versus-host disease (GVHD), which is closely linked to GVL, is the major source of morbidity and mortality following HSCT. ...
However, while HSCT can induce beneficial graft-versus-leukemia (GVL) effect, the adverse effect of graft-versus-host disease (GVHD), …
Combined absence of TRP53 target genes ZMAT3, PUMA and p21 cause a high incidence of cancer in mice.
Brennan MS, Brinkmann K, Romero Sola G, Healey G, Gibson L, Gangoda L, Potts MA, Lieschke E, Wilcox S, Strasser A, Herold MJ, Janic A. Brennan MS, et al. Cell Death Differ. 2024 Feb;31(2):159-169. doi: 10.1038/s41418-023-01250-w. Epub 2023 Dec 18. Cell Death Differ. 2024. PMID: 38110554 Free PMC article.
Knockdown of ZMAT3, an RNA-binding zinc-finger protein involved in regulating alternative splicing, in haematopoietic cells by shRNA caused leukaemia only with the concomitant absence of the PUMA and p21, the critical effectors of TRP53-mediated apoptosis and cell cycle ar …
Knockdown of ZMAT3, an RNA-binding zinc-finger protein involved in regulating alternative splicing, in haematopoietic cells by shRNA caused …
Proteomic profiling of MIS-C patients indicates heterogeneity relating to interferon gamma dysregulation and vascular endothelial dysfunction.
Diorio C, Shraim R, Vella LA, Giles JR, Baxter AE, Oldridge DA, Canna SW, Henrickson SE, McNerney KO, Balamuth F, Burudpakdee C, Lee J, Leng T, Farrel A, Lambert MP, Sullivan KE, Wherry EJ, Teachey DT, Bassiri H, Behrens EM. Diorio C, et al. Nat Commun. 2021 Dec 10;12(1):7222. doi: 10.1038/s41467-021-27544-6. Nat Commun. 2021. PMID: 34893640 Free PMC article.
Optimal infused CD34+ cell dose in multiple myeloma patients undergoing upfront autologous hematopoietic stem cell transplantation.
Pasvolsky O, Marcoux C, Milton DR, Pal B, Tanner MR, Bashir Q, Srour S, Lee J, Saini N, Lin P, Ramdial J, Nieto Y, Tang G, Aljawai Y, Kebriaei P, Becnel MR, Lee HC, Patel KK, Thomas SK, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH. Pasvolsky O, et al. Blood Cancer J. 2024 Oct 31;14(1):189. doi: 10.1038/s41408-024-01165-w. Blood Cancer J. 2024. PMID: 39482325 Free PMC article.
CD20-Targeted Therapy Ablates De Novo Antibody Response to Vaccination but Spares Preestablished Immunity.
Shree T, Shankar V, Lohmeyer JJK, Czerwinski DK, Schroers-Martin JG, Rodriguez GM, Beygi S, Kanegai AM, Corbelli KS, Gabriel E, Kurtz DM, Khodadoust MS, Gupta NK, Maeda LS, Advani RH, Alizadeh AA, Levy R. Shree T, et al. Blood Cancer Discov. 2022 Mar 1;3(2):95-102. doi: 10.1158/2643-3230.BCD-21-0222. Blood Cancer Discov. 2022. PMID: 35015688 Free PMC article.
A cross-standardized flow cytometry platform to assess phenotypic stability in precursor B-cell acute lymphoblastic leukemia (B-ALL) xenografts.
Rolf N, Liu LYT, Tsang A, Lange PF, Lim CJ, Maxwell CA, Vercauteren SM, Reid GSD. Rolf N, et al. Cytometry A. 2022 Jan;101(1):57-71. doi: 10.1002/cyto.a.24473. Epub 2021 Jun 25. Cytometry A. 2022. PMID: 34128309 Free PMC article.
With the continued poor outcome of relapsed acute lymphoblastic leukemia (ALL), new patient-specific approaches for disease progression monitoring and therapeutic intervention are urgently needed. Patient-derived xenografts (PDX) of primary ALL in immune-deficient mice hav …
With the continued poor outcome of relapsed acute lymphoblastic leukemia (ALL), new patient-specific approaches for disease progressi …
21 results